Miriam Frieden

Miriam Frieden is a seasoned Life Science R&D executive with a strong background in both biotech and pharmaceutical sectors, demonstrating impactful leadership and strategic acumen.

She is known for successfully establishing the Search & Evaluation function at Novo Nordisk, expanding the company's portfolio through global partnerships, alliances, and licensing agreements aligned with internal R&D priorities.

Miriam is an adept communicator and relationship-builder, excelling in stakeholder engagement within complex organizational structures.

With proficiency in multiple languages including English, Catalan, Danish, Spanish, German, and French, she brings a multicultural perspective to her endeavors.

Her educational background includes an Executive MBA from the Scandinavian International Management Institute, a PhD in Chemistry from the University of Barcelona, and an MS in Chemistry from King's College London.

Miriam Frieden has held key leadership roles at Novo Nordisk, serving as the Vice President of Search & Evaluation, Senior Director of Competitive Intelligence, and Director of Corporate Strategy.

Prior to her tenure at Novo Nordisk, she was the Director of Business Development at Santaris Pharma, showcasing her diverse experience across various facets of the life sciences industry.